chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician who stated that on approximately 20-NOV-2007 he accidentally administered himself with a dose of varicella virus vaccine live (Oka/Merck) (MSD). He indicated that it was no product confusion, he did not read the label. No symptoms were reported. No other details. There was no product quality complaint. Follow-up information indicated no adverse reaction. No new information. Additional information has been requested.
This case was reported by a other health professional via sales rep and described the occurrence of vaccination failure in a adolescent patient who received BEXSERO for prophylaxis. Co-suspect products included BEXSERO for prophylaxis. On an unknown date, the patient received the 1st dose of BEXSERO and the 2nd dose of BEXSERO. On an unknown date, unknown after receiving BEXSERO and 2 years after receiving BEXSERO and BEXSERO, the patient experienced vaccination failure (serious criteria GSK medically significant) and meningococcal infection (serious criteria GSK medically significant). On an unknown date, the outcome of the vaccination failure and meningococcal infection were unknown. It was unknown if the reporter considered the vaccination failure and meningococcal infection to be related to BEXSERO and BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient was with underlying medical conditions. The patient had disease onset 2 years after completion of primary series. Invasive isolate was not sequenced, at the time of reporting, expected polymerase chain reaction (PCR) testing to be completed soon. This case was considered as suspected vaccination failure since, laboratory confirmation for target disease and disease type were unknown. This case was one of the 4 cases reported by the same reporter. Lab Comments: The patient's invasive isolate was not sequenced, at the time of reporting, expected polymerase chain reaction (PCR).
high fever, vomiting, screaming, unable to sleep-all for a full 24 hrs p/the vax;
Headache, nausea, redness at injection site along with itching, hard, sore bump. Body aches, back ache, could not stand or walk, lightheaded & dizzy, symptoms lasted more than 72 hrs - missed 2 days of work.
Found deceased in crib morning of 9FEB92 by mom of pt; taken to ER declared dead;
This case was reported by a nurse and described the occurrence of confusion in a 32 year old female pt who received hepatitis B vaccine recombinant (Engerix-B) for prophylaxis.  On an unspecified date in September 2003, the pt received her first dose of Engerix-B (Lot # ENG5294B6).  She had no adverse events following the administration.  On 10/10/03, the pt received her second dose of Engerix-B (Lot # ENG5294B6).  A few hours later, she experienced confusion, a chlorine taste in her mouth, flushed feeling, and fuzzy mental status.  The events resolved.  The immunization series of Engerix-B was discontinued.  The nurse considered the events to be possibly related to vaccination with Engerix-B.
back ache; neck ache; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back ache) and NECK PAIN (neck ache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Apr-2021, the patient experienced BACK PAIN (back ache) and NECK PAIN (neck ache). At the time of the report, BACK PAIN (back ache) and NECK PAIN (neck ache) outcome was unknown.
Rash developed approximately 24 hours after vaccine, multiple erythematous patches, raised. Located on neck, chest, abdomen, arms, upper legs. One brief episode of shortness of breath.
Aprox 5-10 min after giving injection, client states she felt a "little lightheaded and dizzy." She stated she never had this happen before. Feet were elevated (She did not want to lie down as suggested). Drank sips of water and observed for aprox. 40 min. Cold compress applied to forehead and neck. BP 140/80, P 72, R 16. BP 138/78, P 72, R 16. Returned to work- appeared and stated she is felt better. C/C'd several times with her vital 3PM.
Vaccine was expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021 (expired vaccine placed in refrigerator); Dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine was expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021 (expired vaccine placed in refrigerator)) and EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Nov-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021 (expired vaccine placed in refrigerator)). At the time of the report, PRODUCT STORAGE ERROR (Vaccine was expired on 13-Oct-2021 and placed in refrigerator on 29-Oct-2021 (expired vaccine placed in refrigerator)) and EXPIRED PRODUCT ADMINISTERED (Dose was given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter was infection control manager.  Concomitant medication of the patient was not reported.  There was no temperature excursion. The reporter reported that there was a confusion between the expiration date printed in the carton and the expiration date when the QR code was scanned.  The patient did not experience any adverse event.  No treatment information was provided by the reporter.
extreme nausea, vomiting, headache, chills  - just took tylenol
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported. No treatment information was provided.
sibling of pa devel varicella zoster;the siblings had not been vaccinated w/varicella vax;
This non-serious event was reported by a health care professional on 13 January 2009.  This patient is one of a cluster of 20 patients; the other 19 are captured in case numbers 2008-03509 (corrected from 2008-03059), 2009-00153 to -00155, and -00157 to -00171.  A female patient received an injection of FLUZONE SV 2008-2009 (lot number U2762A; date and administration details not reported).  On 14 October 2008, she developed ocular respiratory syndrome, complaining of red eyes, nasal congestion, chest tightness, and sore throat.  Outcome was not reported.  Follow-up information was received from the health professional on 13 February 2009.  The patient received the vaccination intramuscularly in the deltoid on 14 October 2008.  Three hours post-vaccination, her eyes became bright red with tearing, nasal congestion, sore throat, and chest tightness.  The event was treated with BENADRYL, MOTRIN, and an ALBUTEROL inhaler.  The red eyes lasted for 24 hours, and the heavy breathing and congestion resolved after four days.  The event recovered.
1 of 2 pts who recvd DTaP/OPV/PPD w/in 24 hrs p/vax devel inject site rxn which included induration, erythema & pain; no fever; induration was 2 1/2" in diameter; required office visit; tx included APAP PRN; recovered;
Fever, headache, body ache - duration approx 18 hours, starting 12 hours after time of vaccination.
Dose administered on 22-Jul-2022, after the expiration date 05-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered on 22-Jul-2022, after the expiration date 05-Jul-2022) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 045L21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered on 22-Jul-2022, after the expiration date 05-Jul-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered on 22-Jul-2022, after the expiration date 05-Jul-2022) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. Date the vial was initially stored in the refrigerator was unknown. The vial did not undergo any temperature excursions. No treatment information were reported.
In Nov 2020, he and his sister had 3rd DTap booster. Immediately after the injection, he looked lethargic, and then a couple hours later he had 103 fever, nausea, vomiting, diarrhea, stomach cramps. Denies rash, swelling, or breathing difficulties. They went to the ED and got antiemetics and ibuprofen with some relief. They started feeling better in 24 hours but their symptoms lasted for a couple days. Dad denies any sick contacts or them feeling ill prior to the vaccines.
Patient received COVID vaccine @ 1508 on 9/23 and was waiting her 15  minutes before leaving when she suddenly developed chest pain which radiated  to the left arm along with shortness of breath and diaphoresis. She was  brought to the treatment room where she had an EKG completed. She was  evaluated and medications were ordered and administered. She had no  swelling of the tongue. she did have difficulty talking, she had  increased shortness of breath and then increased chest pain.  The Following interventions were administered:  Epi Pen--which malfunctioned during administration   Ativan 1mg subling   Epinephrine 0.3mg Sub Q   IV--18 gauge left wrist   Monitor--EKG  completed 1522   oxygen at 2 liter   accu check 327   COVID--negative   ASA 324mg for increasing chest pain   Pepcid 20mg IV   SoluMedrol 125mg  Patient was discharged to Helicopter for transported to Medical Center Emergency Department in stable and improved condition.
not receiving the 2nd dose; cramps on his legs, feet and toes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jul-2021 and was forwarded to Moderna on 27-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (cramps on his legs, feet and toes) and PRODUCT DOSE OMISSION ISSUE (not receiving the 2nd dose) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033b21a) for COVID-19 vaccination.     Concomitant products included METFORMIN and LISINOPRIL for an unknown indication.    On 25-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced MUSCLE SPASMS (cramps on his legs, feet and toes). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (not receiving the 2nd dose). At the time of the report, MUSCLE SPASMS (cramps on his legs, feet and toes) and PRODUCT DOSE OMISSION ISSUE (not receiving the 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient received 1st dose of the Moderna COVID19 on May the 25th 2021 on his left arm. On the 25th of June patient started to experience cramps on his legs, feet and toes mostly at night because of the heat or the vaccine. Also patient should have received the 2nd dose on June the 22nd but he lost the appointment.
After 8 days of getting the vaccine, I experienced redness and a hard bump on the vaccine area. It itches and it's hot. I went to the doctor and they prescribed Triamcinolone Acetonide Cream USP, 0,1% and zyrtec, plus cold compresses.
New front office employee at this PEDS practice with only TDAP and MMR #1 IMM. Proof. Declined titers. AM after rec'ing vaccines, RA site 3x51/2 cm of redness; LA (SQ) site with 61/2x7cm area redness; Positive warm to touch. Afebrile. Office NP rec'd Ibuprofen/BENADRYL PRN. No induration resolved by 08/01/16.
There were no initial symptoms. I went into the doctor for routine blood work, and it came back that I have high cholesterol. This runs in my family; they want to see if there is a underlying condition. I was referred to a cardiologist specialist. I have yet to get an appointment. I've felt fine. No prescriptions or medication have been prescribed for me at this time.
16AUG96 swelling, tenderness;denies temp;lymph node involvement;tx Ibuprofen & ATB;
Child with cellulitis of shoulder, spreading down into axilla, w/ lymphargitis, requiring Keflex treatment.
On 4/29/12 pt was diagnosed with intussusception requiring surgery. Had rotavirus vaccine on 4/27/12.
suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for him/herself. The age at vaccination was not reported. After receiving Shingles vaccine, the patient got shingles three times. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation were not provided.
I had extreme burning in my throat and lungs.  Later the next day my nerves felt like electricity was running thru my whole body.  I was unable to sleep for 6 days. .My body temperature when down 95.3.  It felt like my blood was racing thru my veins,  both arms and legs where tingling and numb feeling.  Then I have had veins rupture on my legs, hands and feet with bruising. These problems are still with me 3 weeks after 1st vaccine.  This is awful and painful!!!!!!  Hopefully I will go back to normal soon.
pt had a severe local reaction with diffuse swelling of the arm and a vessicular eruption twice the size of a silver dollar at the site of the injection of the DTaP
High fever: 102.5 Uncontrollable tremors Dramatically increased heart rate: Supine - 150 bpm, standing or sitting 170 bpm Dizzy spells I eventually took Motrin to help with the above symptoms. It dropped the fever down to 101. My heart rate decreased to between 120-130 bpm.  The above mentioned symptoms persisted from Friday evening until Sunday evening of the same weekend. Monday morning 12/20, the fever was gone, my heart rate was within my normal range and overall I felt fairly normal.
This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. The patient's medical history, drug reactions or allergies and concurrent conditions were not reported. On 11-FEB-2016, the patient was vaccinated with an expired dose of RECOMBIVAX HB, lot number K008988, expiration date 04-FEB-2016 (dose, route and anatomical location were not reported). No adverse effect was reported. There was no concomitant medication reported. Additional information has been requested.
Pt called the evening of vaccination. Severe sore arm  could not lift, nauseous, back pain. She took (2)  motrin. Called her next day she said arm a little  better, nauseousness & back pain were gone
arm was itching, puffy, and had a red rash area at the injection site; arm was itching, puffy, and had a red rash area at the injection site; arm was itching, puffy, and had a red rash area at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (arm was itching, puffy, and had a red rash area at the injection site), VACCINATION SITE RASH (arm was itching, puffy, and had a red rash area at the injection site) and VACCINATION SITE SWELLING (arm was itching, puffy, and had a red rash area at the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003A21A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis. Concomitant products included HYDROXYCHLOROQUINE (HYDROXYCHLOROQUINE                                                                         oral) and METHOTREXATE (METHOTREXATE                                                                             injection) for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (arm was itching, puffy, and had a red rash area at the injection site), VACCINATION SITE RASH (arm was itching, puffy, and had a red rash area at the injection site) and VACCINATION SITE SWELLING (arm was itching, puffy, and had a red rash area at the injection site). At the time of the report, VACCINATION SITE PRURITUS (arm was itching, puffy, and had a red rash area at the injection site), VACCINATION SITE RASH (arm was itching, puffy, and had a red rash area at the injection site) and VACCINATION SITE SWELLING (arm was itching, puffy, and had a red rash area at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Concomitant medications included hydroxychloroquine, methotrexate for Rheumatoid arthritis. patient stopped taking of Methotrexate a week before of first dose  Treatment drugs were not provided  Action taken with mRNA-1273 in response to the event was unknown
Tiredness came on fast and I took a two hour nap.  Went to bed early that same evening.  Woke up following morning feeling rested and fine.
NAUSEA; CHILLS; ;  symptoms lasted approximately 12 hours.  Took Tylenol to relieve symptoms.
An expired dose of the vaccine was given on 1/29/2021; This spontaneous report was received from a physician concerning a 20 month old patient of an unknown gender. There was no information regarding the patient's medical history, concurrent conditions, concomitant medications or drug reactions/allergies.  On 29-JAN-2021, the patient was vaccinated with a dose of  hepatitis a vaccine, inactivated(VAQTA) 0.5ml  lot # T008149 with expiration date of 06-JAN-2021 for prophylaxis (frequency, route of administration, anatomical location, lot number and expiration date were not provided).
Sore and tender arm; Sore and tender arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore and tender arm) and TENDERNESS (Sore and tender arm) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Leukemia. Concurrent medical conditions included Diabetes and Blood pressure high. Concomitant products included AMRUBICIN for an unknown indication.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore and tender arm) and TENDERNESS (Sore and tender arm). At the time of the report, PAIN IN EXTREMITY (Sore and tender arm) and TENDERNESS (Sore and tender arm) outcome was unknown.            The reporter's father who was a patient experienced a sore and tender arm after the second dose of the vaccine. It was also reported that the patient had a history of diabetes, blood pressure issues, and leukemia. Reportedly, the patient was regularly taking a blood pressure pill, medications for their diabetes, and amrubicin.  Other concomitant medications reported included a blood pressure pill and medications for diabetes. No treatment information was provided.   This case was linked to MOD-2021-406930, MOD-2021-406939 (Patient Link).
Site: Pain at Injection Site-Medium, Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hyperventilation-Medium, Systemic: Shakiness-Medium, Systemic: Tinnitus-Medium, Systemic: Weakness-Medium, Additional Details: Patient fainted but remained responsive. Before fainting, patient complained of ringing in ears and problems with breathing (hard to breathe). Patient felt better after about 20 minutes. She didn't want to call another family member or ambulance.  She left by herself and was doing fine.
feeling shaky; like numbness in the arm; low or high blood pressure; she was going to pass out like a panic attack; This is a spontaneous report from a contactable consumer. A 49-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On unspecified date patient experienced feeling shaky, like numbness in the arm, low or high blood pressure and she felt like she was going to pass out like a panic attack she had been in and out of the emergency and hospital after receiving the first dose of the vaccine. It's been happening for a week. They advised that this was not a severe allergic reaction because it would not last this long. Read the entire list of the reported side effects associated with the vaccine. Caller mentioned her mother had reported none of these side effects. Informed caller they might not have the list of all the possible side effects associated with the vaccine. They could not say these symptoms have not been reported post vaccination, but this information will be sent for further escalation. For treatment recommendation please speak to HCP for more information. The side effects generally last 1-2 days. However, we have limited information regarding the duration of severe allergic reaction. The recovery period may vary from person to person. Outcome of the events was reported as unknown.  No follow-up attempts are possible. Information about batch number cannot be obtained.